Risk to all or none?. A comparative analysis of controversies in the health risk assessment of Bisphenol A.

Reproductive Toxicology

Volumn 29, Issue 2, 2010, Pages 132-146

  Beronius, Anna ^a   Rudén, Christina ^b   Håkansson, Helen ^a   Hanberg, Annika ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

Assessment factor; Bisphenol A; Data evaluation; Data interpretation; Endocrine disruptor; Low dose effect; Risk assessment

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL;

ARTICLE; CHEMICAL ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXPERT SYSTEM; FACTORIAL ANALYSIS; HEALTH HAZARD; MEDICAL RESEARCH; POLICY; PRENATAL EXPOSURE; RISK ASSESSMENT;

ANIMALS; DATABASES, BIBLIOGRAPHIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCRINE DISRUPTORS; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; MICE; NO-OBSERVED-ADVERSE-EFFECT LEVEL; PHENOLS; PUBLIC POLICY; RATS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; RISK ASSESSMENT; SEX FACTORS; WORLD HEALTH;

EID: 77949568254     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2009.11.007     Document Type: Article

References (53)

1. WHO-International Programme on Chemical Safety. Global assessment of the state-of-the-science of endocrine disruptors. 2002. Available on-line at: http://www.who.int/ipcs/.
2. National Toxicology Program. National Toxicology Program's Report of the endocrine disruptors low dose peer review. 2001. Available on-line at: ntp.niehs.nih.gov.
3. European Union. Position of the European Parliament adopted at second reading on 13 January 2009 with a view to the adoption of Regulation (EC) No./2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC. 2009. Available on-line at: http://www.europarl.europa.eu/.
4. European Chemicals Bureau. European Union risk assessment report: 4,4′-isopropylidenediphenol (Bisphenol-A). 2003. Available on-line at: http://ecb.jrc.ec.europa.eu/.
5. European Chemicals Bureau. Updated risk assessment of 4,4′-isopropylidenediphenol (Bisphenol-A). 2008. Available on-line at: http://ecb.jrc.ec.europa.eu/.
6. European Food Safety Authority. Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food on a request from the Commission related to 2,2-bis(4-hydroxyphenyl)propane (bisphenol A). 2006. Available on-line at: http://www.efsa.europa.eu/.
7. European Food Safety Authority. Toxicokinetics of Bisphenol A. Scientific Opinion of the Panel on Food additives, Flavourings, Processing aids and Materials in Contact with Food (AFC). 2008. Available on-line at: http://www.efsa.europa.eu/.
8. European Commission-Health & Consumer Protection Directorate-General. Opinion of the Scientific Committee on Food on Bisphenol A. 2002. Available on-line at: http://ec.europa.eu/food/index_en.htm.
9. National Toxicology Program Center for the Evaluation of Risks to Human Reproduction. Monograph on the potential human reproductive and developmental effects of bisphenol A. 2008. Available on-line at: http://cerhr.niehs.nih.gov/.
10. US Food and Drug Administration. Draft assessment of bisphenol A for use in food contact applications. 2008. Available on-line at: http://www.fda.gov/.
11. vom Saal F.S., Belcher S.M., Guillette L.J., Hauser R., Myers J.P. Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol 2007, 24:131-138.
12. Health Canada. Screening assessment for the Challenge Phenol, 4,4′-(1-methylethylidene)bis-(Bisphenol A). 2008. Available on-line at: http://www.hc-sc.gc.ca/.
13. Japanese National Institute of Advanced Industrial Science and Technology Risk Assessment Document Series No 4: Bisphenol A. 2005. Available on-line at: http://www.aist.go.jp/.
14. Calafat A.M., Ye X., Wong L.-Y., Reidy J.A., Needham L.L. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect 2008, 116:39-44.
15. Vandenberg L.N., Hauser R., Marcus M., Olea N., Welshons W.V. Human exposure to bisphenol A (BPA). Reprod Toxicol 2007, 24:139-177.
16. Tyl R.W., Myers C.B., Marr M.C., Thomas B.F., Keimowitz A.R., Brine D.R., et al. Three-generation reproductive toxicity study of dietary bisphenol A in CD Sprague-Dawley rats. Toxicol Sci 2002, 68:121-146.
17. Tyl R.W., Myers C.B., Marr M.C., Sloan C.S., Castillo N.P., Veselica M.M., et al. Two-generation reproductive toxicity study of dietary bisphenol A in CD-1 (Swiss) mice. Toxicol Sci 2008, 104:362-384.
18. Nagel S.C., vom Saal F.S., Thayer K.A., Dhar M.D., Boechler M., Welshons W.V. Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ Health Perspect 1997, 105:70-76.
19. vom Saal F.S., Cooke P.S., Buchanan D.L., Palanza P., Thayer K.A., Nagel S.C., et al. A physiologically based approach to the study of bisphenol A and other estrogenic chemicals on the size of reproductive organs, daily sperm production, and behavior. Toxicol Ind Health 1998, 14:239-260.
20. Nikaido Y., Yoshizawa K., Danbara N., Tsujita-Kyutoku M., Yuri T., Uehara N., et al. Effects of maternal xenoestrogen exposure on development of the reproductive tract and mammary gland in female CD-1 mouse offspring. Reprod Toxicol 2004, 18:803-811.
21. Durando M., Kass L., Piva J., Sonnenschein C., Soto A.M., Luque E.H., et al. Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats. Environ Health Perspect 2007, 115:80-86.
22. Markey C.M., Wadia P.R., Rubin B.S., Sonnenschein C., Soto A.M. Long-term effects of fetal exposure to low doses of the xenoestrogen bisphenol-A in the female mouse genital tract. Biol Reprod 2005, 72:1344-1351.
23. Timms B.G., Howdeshell K.L., Barton L., Bradley S., Richter C.A., vom Saal F.S. Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra. PNAS 2005, 102:7014-7019.
24. Gupta C. Reproductive malformation of the male offspring following maternal exposure to estrogenic chemicals. PSEBM 2000, 224:61-68.
25. Ho S.-M., Tang W.-Y., Belmonte de Frausto J., Prins G.S. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res 2006, 66:5624-5632.
26. Aikawa H., Koyama S., Matsuda M., Nakahashi K., Akazome Y., Mori T. Relief effect of vitamin A on the decreased motility of sperm and the increased incidence of malformed sperm in mice exposed neonatally to bisphenol A. Cell Tissue Res 2004, 315:119-124.
27. Nakagami A., Negishi T., Kawasaki K., Imai N., Nishida Y., Ihara T., et al. Alterations in male infant behaviors towards its mother by prenatal exposure to bisphenol A in cynomolgus monkeys (Macaca fascicularis) during early suckling period. Psychoneuroendocrinology 2009, 34:1189-1197.
28. Negishi T., Kawasaki K., Suzaki S., Maeda H., Ishii Y., Kyuwa S., et al. Behavioral alterations in response to fear-provoking stimuli and tranylcypromine induced by perinatal exposure to bisphenol A and nonylphenol in male rats. Environ Health Perspect 2004, 112:1159-1164.
29. Ryan B.C., Vandenbergh J.G. Developmental exposure to environmental estrogens alters anxiety and spatial memory in female mice. Horm Behav 2006, 50:85-93.
30. Adriani W., Seta D.D., Dessi-Fulgheri F., Farabollini F., Laviola G. Altered profiles of spontaneous novelty seeking, impulsive behavior, and response to D-amphetamine in rats perinatally exposed to bisphenol A. Environ Health Perspect 2003, 111:395-401.
31. Carr R.L., Bertasi F.R., Betancourt A.M., Bowers S.D., Gandy B.S., Ryan P.L., et al. Effect of neonatal rat bisphenol A exposure on performance in the Morris water maze. J Tox Environ Health Part A 2003, 66:2077-2088.
32. vom Saal F.S., Nagel S.C., Timms B.G., Welshons W.V. Implications for human health of the extensive bisphenol A literature showing adverse effects at low doses: a response to attempts to mislead the public. Toxicology 2005, 212:244-252.
33. Lang I.A., Galloway T.S., Scarlett A., Henley W.E., Depledge M., Wallace R.B., et al. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 2008, 300:1303-1310.
34. Sugiura-Ogasawara M., Ozaki Y., Sonta S., Makino T., Suzumori K. Exposure to bisphenol A is associated with recurrent miscarriage. Hum Reprod 2005, 20:2325-2329.
35. Takeuchi T., Tsutsumi O., Ikezuki Y., Takai Y., Taketani Y. Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. Endocrine J 2004, 51:165-169.
36. Cummings A.M., Stoker T., Kavlock R.J. Gender-based differences in endocrine and reproductive toxicity. Env Res 2007, 104:96-107.
37. Falk-Filipsson A., Hanberg A., Victorin K., Warholm M., Wallen M. Assessment factors-applications in health risk assessment of chemicals. Environ Res 2007, 104:108-127.
38. Rudén C. The use and evaluation of primary data in 29 trichloroethylene carcinogen risk assessments. Reg Toxicol Pharmacol 2001, 34:3-16.
39. Rudén C. Interpretations of primary carcinogenicity data in 29 trichloroethylene risk assessments. Toxicology 2001, 169:209-225.
40. Richter C.A., Birnbaum L.S., Farabollini F., Newbold R.R., Rubin B.S., Talsness C.E., et al. In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol 2007, 24:199-224.
41. Wetherill Y.B., Akingbemi B.T., Kanno J., McLachlan J.A., Nadal A., Sonnenschein C., et al. In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol 2007, 24:178-198.
42. Crain D.A., Eriksen M., Iguchi T., Jobling S., Laufer H., LeBlanc G.A., et al. An ecological assessment of bisphenol A: evidence from comparative biology. Reprod Toxicol 2007, 24:225-239.
43. Keri R.A., Ho S.-M., Hunt P.A., Knudsen K.E., Soto A.M., Prins G.S. An evaluation of evidence for the earcinogenic activity of bisphenol A. Reprod Toxicol 2007, 24:240-252.
44. Shin B.S., Kim C.H., Jun Y.S., Kim D.H., Lee B.M., Yoon C.H., et al. Physiologically based pharmacokinetics of bisphenol A. J Toxicol Environ Health A 2004, 67:1971-1985.
45. Takeuchi T., Tsutsumi O. Serum bisphenol A concentrations showed gender differences, possibly linked to androgen levels. Biochem Biophys Res Commun 2002, 291:76-78.
46. Dekant W., Völkel W. Human exposure to bisphenol A by biomonitoring: methods, results and assessment of environmental exposures. Toxicol Appl Pharmacol 2008, 228:114-134.
47. Stahlhut R.W., Welshons W.V., Swan S.H. Bisphenol A data in NHANES suggest longer than expected half-life, substantial nonfood exposure, or both. Environ Health Perspect 2009, 117:784-789.
48. Diamanti-Kandarakis E., Bourguignon J.-P., Giudice L.C., Hauser R., Prins G.S., Soto A.M., et al. Endocrine-disrupting chemicals. An Endocrine Society scientific statement. Endocrine Rev 2009, 30:293-342.
49. Welshons W.V., Thayer K.A., Judy B.M., Taylor J.A., Curran E.M., vom Saal F.S. Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ Health Perspect 2003, 111:994-1006.
50. Myers J.P., vom Saal F.S., Akingbemi B.T., Arizono K., Belcher S., Colborn T., et al. Why public health agencies cannot depend on good laboratory practices as a criterion for selecting data: the case of bisphenol A. Environ Health Perspect 2009, 117:309-315.
51. Tyl R.W. Basic Exploratory Research Versus Guideline-Compliant Studies Used for Hazard Evaluation and Risk Assessment: Bisphenol A as a Case Study. Environ Health Perspect 2009, 117:1644-1651.
52. European Chemicals Bureau. Technical Guidance Document on Risk Assessment Part I. 2003. Available on-line at: http://ecb.jrc.ec.europa.eu/.
53. Beronius A., Rudén C., Hanberg A., Håkansson H. Health risk assessment procedures for endocrine disrupting compounds within different regulatory frameworks in the European Union. Reg Toxicol Pharmacol 2009, 55:111-122.